What's breaking now, across thousands of outlets.
Eli Lilly impressed with its amylin-Zepbound combination data. Elsewhere, Novo demonstrated continued weight loss following a switch to oral and AbbVie and Boehringer gave glimpses into their contenders.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The shortlist of five finalists to serve as the next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria was published on Wednesday (30 September), launching the final phase…
(MedPage Today) -- In upstate New York, a nurse was choked with a stethoscope by a patient in the emergency room, according to police.
Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.
A new review suggests that depression might be better understood as a collection of symptoms as opposed to a single brain disorder.
Economists analyzed data from more than 120,000 people across 121 countries—including 42 high-income countries and 79 low- and middle-income countries—using the 2021 Lloyd's Register Foundation World…
Mumbai, October 1, 2026: The Food and Drug Administration (FDA) has suspended the food licences of several eateries, bakeries, catering units and institutional food establishments across Mumbai after…
